Parkinson’s Disease Co-Pathology Carries a Distinct Immunometabolic Signature
Early-stage Parkinson’s disease with Alzheimer’s co-pathology shows heightened inflammation, immune-cell activation, and altered mononuclear-cell metabolism.
From stroke to neurodegeneration — the science and its clinical impact.
From stroke to neurodegeneration — the science and its clinical impact.